Alaffia Wire
$55M Series B closed, Feb 2026 Led by Transformation Capital Total funding tops $73M $100M+ saved for customers since launch 97% clinical fact-extraction accuracy Forbes 30 Under 30, Healthcare 2023 Built with his older sister, Adun Akanni Ex-Goldman Sachs banker
TJ Ademiluyi, CEO and co-founder of Alaffia Health
TJ Ademiluyi. He priced tech IPOs, then went back to the family trade: reading the bill.
CEO & Co-Founder / Alaffia Health / New York

TJ
Ademiluyi

He grew up around a family medical-billing business. Now he builds AI that reads a patient's whole record and checks whether the hospital's math holds up.

Payment integrity, run on agentic AI
Who he is now

The boring problem nobody wanted

About eighty cents of every hundred dollars in American medical claims is fine. The other twenty is where TJ Ademiluyi lives. He runs Alaffia Health, a New York company that reviews medical claims for health plans, and his pitch is unglamorous in the way that large numbers usually are: roughly 80% of US medical claims carry at least one error, and something like $300 billion a year leaks out of the system as waste and fraud. Most of it, he is careful to say, is not villainy. It is human error, opaque processing, and incentives that point in slightly different directions.

Alaffia's product is a piece of software that does what a very patient auditor would do if the auditor never slept: it extracts the clinical facts out of a medical record, lines those facts up against what the provider billed, and checks the whole thing against reimbursement policy and clinical guidelines. When the bill and the record disagree, it flags the gap before the money moves. The company says it hits 97% accuracy pulling those facts out of messy documentation, saves an average of more than 20% on high-cost facility claims, and has returned over $100 million to its customers since launch.

What makes the story worth telling is not the dashboard. It is that Ademiluyi did not stumble into healthcare billing. He was raised next to it.

By the numbers
$55M
Series B, Feb 2026
$73M+
Total raised
97%
Fact-extraction accuracy
$100M+
Saved for customers
The family trade

Healthcare, he says, was in the DNA

The company that became Alaffia started at a kitchen-table education in how the money actually moves.

Ademiluyi and his older sister, Adun Akanni, grew up in a family that ran a medical-billing business. That is an unusual thing to be an expert in by the time you are a teenager, and it turned out to be the kind of expertise that is hard to buy and hard to fake. The two of them watched, up close, where claims got stuck, where errors hid, and where the friction between a hospital and an insurer turned into wasted money.

He did not go straight into it. He studied finance at the University of Maryland's Robert H. Smith School of Business, graduating in 2017, and cut his teeth as an investor at 301 Ventures, the university's student-run venture fund. Then he went to Goldman Sachs as an investment banker, working on mergers, private placements, and IPOs for technology companies - the kind of resume that usually points a person toward more finance, not toward the plumbing of hospital reimbursement.

In 2020 he and Akanni started Alaffia instead, taking what they had absorbed from the family business and pointing early machine learning at it. She is the COO. He is the CEO. The name is a West African greeting meaning peace, health, and wellness, which is a lot to ask of a claims-review platform, and also exactly the point.

"The majority of the waste in the system results from natural human error, lack of transparency in claims processing, and misaligned incentives."
- TJ Ademiluyi
The design choice

The AI does the lifting. The clinician makes the call.

01 / Read

It reads the record

Agentic AI extracts the key clinical facts from the patient's medical record and the supporting documentation - the messy part most systems skip.

02 / Check

It checks the bill

Those facts get compared against what the provider billed, and against reimbursement policy and clinical guidelines, to see where the two disagree.

03 / Defer

A human decides

The AI surfaces clear findings; licensed clinicians review the output and make the final determination. Ademiluyi calls this keeping clinicians "at the helm."

This is the part that separates Alaffia from the usual AI story, where the machine replaces the expert and everyone claps or panics. Ademiluyi's argument is the opposite: in an industry governed by ever-changing compliance rules and touchy provider relationships, the AI that decides on its own is a liability. The AI that hands a well-organized case to a clinician is an asset. His words: "This balance allows Alaffia to deliver meaningful savings without increasing compliance or provider-relations risk."

The platform now spans payment integrity, utilization management, and appeals across the claims lifecycle, aimed at regional and national health plans. The reported results are the kind investors like: average savings above 20% on high-cost facility claims, roughly 5x customer ROI, and turnaround times that dropped from weeks to days.

The path

From a student fund to a Series B

2017

Graduates in finance from the University of Maryland's Smith School, after investing with the student-run 301 Ventures fund.

2017

Joins Goldman Sachs as an investment banker - M&A, private placements, and tech IPOs.

2020

Co-founds Alaffia Health in New York with his sister Adun Akanni, built on the family's medical-billing business.

2023

Named to Forbes' 30 Under 30 in Healthcare. Alaffia crosses 300,000 members.

2026

Closes a $55M Series B led by Transformation Capital; total funding passes $73M. Todd Cozzens joins the board.

In his words

On trust, machines, and the point of all this

"We founded Alaffia to tackle these issues using nascent machine learning and AI."

"Clinicians remain at the helm, reviewing the AI's outputs and making the final determination."

"Our ambition at Alaffia is to help create a system where cost containment doesn't come at the expense of trust."

Things worth knowing
01

He co-founded the company with his own older sister, who runs operations as COO.

02

"Alaffia" is a West African greeting meaning peace, health, and wellness.

03

He left a Goldman Sachs desk pricing tech IPOs to work on medical claims.

04

Made Forbes 30 Under 30 at 29, having already built a multi-million-dollar company.

"A system where cost containment doesn't come at the expense of trust."
- What he's building toward

Share this profile

Quick facts: TJ Ademiluyi

TJ Ademiluyi is the CEO and co-founder of Alaffia Health, a New York healthcare-technology company that pairs licensed clinicians with agentic AI to review medical claims for health plans. Raised in a family that ran a medical-billing business, he traded a finance career at Goldman Sachs to build software that reads patient records, checks provider bills against policy, and flags overpayments before they are paid. He founded the company in 2020 with his older sister, Adun Akanni, was named to Forbes' 2023 30 Under 30 in Healthcare, and in February 2026 raised a $55 million Series B led by Transformation Capital, bringing total funding above $73 million.

Role
CEO & Co-Founder at Alaffia Health
Organizations
Alaffia Health, Goldman Sachs, 301 Ventures
Nationality
American
Education
B.S. in Finance, University of Maryland, Robert H. Smith School of Business
Known for
Forbes 30 Under 30 in Healthcare, 2023, Co-founded and leads Alaffia Health, which has helped customers save over $100 million in medical costs since launch, Raised a $55 million Series B in February 2026, led by Transformation Capital, pushing total funding past $73 million

Last updated: